Chemify secures over US $50 million Series B to drive global digital chemistry platform

Chemify, a Glasgow-based deep-tech company revolutionising molecular design and synthesis, has raised over $50 million in an oversubscribed Series B round co-led by Wing Venture Capital and Insight Partners. The funding will support global expansion of its Chemputation platform and Chemifarm facilities—fully automated labs integrating AI, robotics, and a vast library of validated chemical reactions.

Chemify’s vision is to become the digital backbone of chemistry, enabling rapid, on-demand molecule creation for pharmaceuticals, biotech, and advanced materials. The investment will accelerate the rollout of digital chemistry hubs worldwide, including a new Silicon Valley facility led by CTO Mike Bell.

Founded in 2022, Chemify combines automation, computation, and AI to transform chemical synthesis into a programmable process. With this new backing, the company aims to lead the discovery of life-changing medicines and materials, setting a new global standard for molecular innovation.